Effects of MRI image normalization techniques in prostate cancer radiomics

Phys Med. 2020 Mar:71:7-13. doi: 10.1016/j.ejmp.2020.02.007. Epub 2020 Feb 18.

Abstract

The variance in intensities of MRI scans is a fundamental impediment for quantitative MRI analysis. Intensity values are not only highly dependent on acquisition parameters, but also on the subject and body region being scanned. This warrants the need for image normalization techniques to ensure that intensity values are consistent within tissues across different subjects and visits. Many intensity normalization methods have been developed and proven successful for the analysis of brain pathologies, but evaluation of these methods for images of the prostate region is lagging. In this paper, we compare four different normalization methods on 49 T2-w scans of prostate cancer patients: 1) the well-established histogram normalization, 2) the generalized scale normalization, 3) an extension of generalized scale normalization called generalized ball-scale normalization, and 4) a custom normalization based on healthy prostate tissue intensities. The methods are compared qualitatively and quantitatively in terms of behaviors of intensity distributions as well as impact on radiomic features. Our findings suggest that normalization based on prior knowledge of the healthy prostate tissue intensities may be the most effective way of acquiring the desired properties of normalized images. In addition, the histogram normalization method outperform the generalized scale and generalized ball-scale methods which have proven superior for other body regions.

Keywords: Image normalization; MRI; Prostate cancer; Radiomics.

Publication types

  • Clinical Trial, Phase II

MeSH terms

  • Algorithms
  • Humans
  • Image Processing, Computer-Assisted / methods
  • Machine Learning
  • Magnetic Resonance Imaging*
  • Male
  • Prospective Studies
  • Prostate / diagnostic imaging
  • Prostate-Specific Antigen / analysis
  • Prostatic Neoplasms / diagnostic imaging*
  • Prostatic Neoplasms / radiotherapy
  • Radiometry / methods

Substances

  • Prostate-Specific Antigen